The story has been corrected to reflect the correct amount of Guardant Health's financing round in January 2016.

NEW YORK (GenomeWeb) – Guardant Health today announced it has raised $360 million to finance a new goal to sequence the tumor DNA of more than 1 million cancer patients within five years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.